223 related articles for article (PubMed ID: 30360813)
21. Silica-based nanoprobes for biomedical imaging and theranostic applications.
Vivero-Escoto JL; Huxford-Phillips RC; Lin W
Chem Soc Rev; 2012 Apr; 41(7):2673-85. PubMed ID: 22234515
[TBL] [Abstract][Full Text] [Related]
22. High-Performance Chromatographic Characterization of Surface Chemical Heterogeneities of Fluorescent Organic-Inorganic Hybrid Core-Shell Silica Nanoparticles.
Gardinier TC; Kohle FFE; Peerless JS; Ma K; Turker MZ; Hinckley JA; Yingling YG; Wiesner U
ACS Nano; 2019 Feb; 13(2):1795-1804. PubMed ID: 30629425
[TBL] [Abstract][Full Text] [Related]
23. Radiolabeling Silica-Based Nanoparticles via Coordination Chemistry: Basic Principles, Strategies, and Applications.
Ni D; Jiang D; Ehlerding EB; Huang P; Cai W
Acc Chem Res; 2018 Mar; 51(3):778-788. PubMed ID: 29489335
[TBL] [Abstract][Full Text] [Related]
24. Mesoporous silica nanoparticles in nanomedicine applications.
Manzano M; Vallet-Regí M
J Mater Sci Mater Med; 2018 May; 29(5):65. PubMed ID: 29737405
[TBL] [Abstract][Full Text] [Related]
25. Biodegradable Oxamide-Phenylene-Based Mesoporous Organosilica Nanoparticles with Unprecedented Drug Payloads for Delivery in Cells.
Croissant JG; Fatieiev Y; Julfakyan K; Lu J; Emwas AH; Anjum DH; Omar H; Tamanoi F; Zink JI; Khashab NM
Chemistry; 2016 Oct; 22(42):14806-14811. PubMed ID: 27258139
[TBL] [Abstract][Full Text] [Related]
26. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 2: Imaging, diagnostic, and therapeutic applications.
Son SJ; Bai X; Lee SB
Drug Discov Today; 2007 Aug; 12(15-16):657-63. PubMed ID: 17706548
[TBL] [Abstract][Full Text] [Related]
27. Benzene-Bridged Organosilica Modified Mesoporous Silica Nanoparticles via an Acid-Catalysis Approach.
Zhang Y; Gu Z; Liu Y; Hu W; Liu C; Shu W; Wang Y; Yu C
Langmuir; 2021 Mar; 37(8):2780-2786. PubMed ID: 33591191
[TBL] [Abstract][Full Text] [Related]
28. Drug delivery/imaging multifunctionality of mesoporous silica-based composite nanostructures.
Chen Y; Chen H; Shi J
Expert Opin Drug Deliv; 2014 Jun; 11(6):917-30. PubMed ID: 24746014
[TBL] [Abstract][Full Text] [Related]
29. Synthetic strategies for nonporous organosilica nanoparticles from organosilanes.
Zou H; Ren Y
Nanoscale; 2023 Jun; 15(25):10484-10497. PubMed ID: 37326150
[TBL] [Abstract][Full Text] [Related]
30. Silica-based multimodal/multifunctional nanoparticles for bioimaging and biosensing applications.
Tallury P; Payton K; Santra S
Nanomedicine (Lond); 2008 Aug; 3(4):579-92. PubMed ID: 18694319
[TBL] [Abstract][Full Text] [Related]
31. Optically active organic and inorganic nanomaterials for biological imaging applications: A review.
Sowmiya P; Dhas TS; Inbakandan D; Anandakumar N; Nalini S; Suganya KSU; Remya RR; Karthick V; Kumar CMV
Micron; 2023 Sep; 172():103486. PubMed ID: 37262930
[TBL] [Abstract][Full Text] [Related]
32. Enzyme Armoring by an Organosilica Layer: Synthesis and Characterization of Hybrid Organic/Inorganic Nanobiocatalysts.
Correro MR; Sykora S; Corvini PF; Shahgaldian P
Methods Enzymol; 2017; 590():77-91. PubMed ID: 28411651
[TBL] [Abstract][Full Text] [Related]
33. Hybrid Decorated Core@Shell Janus Nanoparticles as a Flexible Platform for Targeted Multimodal Molecular Bioimaging of Cancer.
Sánchez A; Ovejero Paredes K; Ruiz-Cabello J; Martínez-Ruíz P; Pingarrón JM; Villalonga R; Filice M
ACS Appl Mater Interfaces; 2018 Sep; 10(37):31032-31043. PubMed ID: 30141615
[TBL] [Abstract][Full Text] [Related]
34. Hybrid nanoparticles for cancer imaging and therapy.
He C; Lin W
Cancer Treat Res; 2015; 166():173-92. PubMed ID: 25895869
[TBL] [Abstract][Full Text] [Related]
35. Biodegradable Silica-Based Nanoparticles: Dissolution Kinetics and Selective Bond Cleavage.
Croissant JG; Brinker CJ
Enzymes; 2018; 43():181-214. PubMed ID: 30244807
[TBL] [Abstract][Full Text] [Related]
36. Mesoporous Silica and Organosilica Nanomaterials as UV-Blocking Agents.
Knežević NŽ; Ilić N; D Okić V; Petrović R; Janaćković DOE
ACS Appl Mater Interfaces; 2018 Jun; 10(24):20231-20236. PubMed ID: 29863843
[TBL] [Abstract][Full Text] [Related]
37. Interlocked systems in nanomedicine.
Ornelas-Megiatto C; Becher TB; Megiatto JD
Curr Top Med Chem; 2015; 15(13):1236-56. PubMed ID: 25858133
[TBL] [Abstract][Full Text] [Related]
38. Mesoporous silica nanoparticles for stimuli-responsive controlled drug delivery: advances, challenges, and outlook.
Song Y; Li Y; Xu Q; Liu Z
Int J Nanomedicine; 2017; 12():87-110. PubMed ID: 28053526
[TBL] [Abstract][Full Text] [Related]
39. Core-shell hierarchical mesostructured silica nanoparticles for gene/chemo-synergetic stepwise therapy of multidrug-resistant cancer.
Sun L; Wang D; Chen Y; Wang L; Huang P; Li Y; Liu Z; Yao H; Shi J
Biomaterials; 2017 Jul; 133():219-228. PubMed ID: 28441616
[TBL] [Abstract][Full Text] [Related]
40. Dendritic Mesoporous Nanoparticles: Structure, Synthesis and Properties.
Xu C; Lei C; Wang Y; Yu C
Angew Chem Int Ed Engl; 2022 Mar; 61(12):e202112752. PubMed ID: 34837444
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
